Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
Type 1 diabetes mellitus (T1DM) is an autoimmune disease resulting from loss of insulin-secreting β-cells in islets of Langerhans. The loss of β-cells is initiated when self-tolerance to β-cell-derived contents breaks down, which leads to T cell-mediated β-cell damage and, ultimately, β-cell apoptos...
Saved in:
Main Authors: | Qing-Rong Liu (Author), Kanikkai Raja Aseer (Author), Qin Yao (Author), Xiaoming Zhong (Author), Paritosh Ghosh (Author), Jennifer F. O'Connell (Author), Josephine M. Egan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice
by: Kanikkai Raja Aseer, et al.
Published: (2024) -
Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906]
by: Kanikkai Raja Aseer, et al.
Published: (2024) -
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018) -
Voltage dependence of the cannabinoid CB1 receptor
by: Esty Goldberger, et al.
Published: (2022) -
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
by: Ken Soderstrom, et al.
Published: (2017)